Drugs / KCL
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00460499 Comparator | Jul 2004 → Mar 2015 | glucose metabolism disease | American Heart Association | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KCL | “These patients will receive D5W+80unitsInsulin+40mEqKCL IV to keep blood glucose between 120-180mg/dl” NCT00460499 ↗ |
| Route | Intravenous | “D5W+80unitsInsulin+40mEqKCL IV” NCT00460499 ↗ |